Therapeutic compounds and uses thereof

Details Therapeutic compounds and uses thereof Therapeutic compounds and uses thereof

2011-03-01

2011-03-01

Chandrakumar, Nizal S (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07897765

ABSTRACT:
Compounds of formula (I) are described hereinThe compounds can be used, for example, to modulate growth hormone secretagogue receptor (GHS-R). In some instances, the compounds can be used to treat obesity.

REFERENCES:
patent: 5492916 (1996-02-01), Morriello et al.
patent: 5492920 (1996-02-01), Chen et al.
patent: 5494919 (1996-02-01), Morriello et al.
patent: 5536716 (1996-07-01), Chen et al.
patent: 5559128 (1996-09-01), Chakravarti et al.
patent: 5578593 (1996-11-01), Chen et al.
patent: 5622973 (1997-04-01), Morriello et al.
patent: 5652235 (1997-07-01), Chen et al.
patent: 5721250 (1998-02-01), Morriello et al.
patent: 5721251 (1998-02-01), Chen et al.
patent: 5723616 (1998-03-01), Houghton et al.
patent: 5767124 (1998-06-01), Draper et al.
patent: 5783582 (1998-07-01), Guo et al.
patent: 5830433 (1998-11-01), Dean et al.
patent: 5877182 (1999-03-01), Nargund et al.
patent: 5880125 (1999-03-01), Nargund
patent: 6358951 (2002-03-01), Carpino
patent: 6420376 (2002-07-01), Tata et al.
patent: WO 2005/097788 (2005-10-01), None
Elliot, J.M., et al., “Serine Derived NK1 Antagonist 1: The effects of Modification to the Serine Substituents,”Bioorganic&Medicinal Chem. Lettersvol. 8: 1845-1850 (1998).
Supplementary Partial European Search Report from corresponding EP application No. EPP290691 dated May 6, 2009.

Affiliated with

Also associated with

Rating

Therapeutic compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2741041